Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1501 Articles

Chris Lange | Mar 18, 2016 at 12:40 PM EDT

Pfizer Posts Positive Late-Stage Results in Colitis Trials

Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in…

Lee Jackson | Mar 18, 2016 at 8:25 AM EDT

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

So what are investors to do in a continued low rate environment? Buy the best stocks out there, especially ones…

Chris Lange | Mar 15, 2016 at 10:20 AM EDT

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Paul Ausick | Mar 11, 2016 at 4:01 PM EST

The 4 Stocks That Dominated the Dow on Friday

March 11, 2016: Markets opened higher again on Friday and held on to the early gains all day. Energy and…

Lee Jackson | Mar 11, 2016 at 8:35 AM EST

Merrill Lynch Has 4 Outstanding Growth Stocks to Buy That Yield More Than 4%

24/7 Wall St. screened the Merrill Lynch research data base for solid growth ideas that also paid a dividend of…

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Trey Thoelcke | Mar 10, 2016 at 7:55 AM EST

The 5 Most Shorted NYSE Stocks: Chesapeake Energy Leads the Trend

Most of the stocks traded on the New York Stock Exchange with the greatest number of shares short saw their…

Jon C. Ogg | Mar 8, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

The top analyst upgrades, downgrades and initiations seen on Tuesday, March 8, include AutoNation, Celldex Therapeutics, EP Energy, Shopify, Sony,…

Lee Jackson | Mar 3, 2016 at 8:35 AM EST

Dogs of the Dow on Fire in 2016: 4 to Buy With Yields of 4% or More

So far this year, based on changes in yields, the Dogs of the Dow are doing much better, as their…

Paul Ausick | Feb 29, 2016 at 4:01 PM EST

The 4 Stocks That Sank the DJIA on Monday

February 29, 2016: Markets opened lower on Monday before rising to intra-day highs at around noon, and then dipping to…

Lee Jackson | Feb 29, 2016 at 10:45 AM EST

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these…

Paul Ausick | Feb 26, 2016 at 4:01 PM EST

The 4 Stocks That Weighed on the DJIA Friday

February 26, 2016: Markets opened higher on Friday on rising oil prices in Asia and Europe which turned into lower…

Lee Jackson | Feb 26, 2016 at 8:20 AM EST

3 Highest Yielding Merrill Lynch US 1 Portfolio Stocks to Buy Now

For the long haul, these three stock should provide a much better avenue for total return and continue to increase…

Chris Lange | Feb 25, 2016 at 8:10 AM EST

Short Sellers Increase Bets in Major Pharma

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

1 … 52 53 54 55 56 … 101

Pfizer : PFE

All Pfizer Articles

Pfizer Posts Positive Late-Stage Results in Colitis Trials

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Jefferies Top Drug Stocks for the Rest of 2016

The 4 Stocks That Dominated the Dow on Friday

Merrill Lynch Has 4 Outstanding Growth Stocks to Buy That Yield More Than 4%

Major Pharma Short Interest Takes a Small Step Back

The 5 Most Shorted NYSE Stocks: Chesapeake Energy Leads the Trend

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

Dogs of the Dow on Fire in 2016: 4 to Buy With Yields of 4% or More

The 4 Stocks That Sank the DJIA on Monday

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

The 4 Stocks That Weighed on the DJIA Friday

3 Highest Yielding Merrill Lynch US 1 Portfolio Stocks to Buy Now

Short Sellers Increase Bets in Major Pharma

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Nvidia’s Biggest Threat Is This: Everyone Is Desperate to Stop Paying Nvidia Prices.

Does IREN Have the Inside Track on This $22 Billion Opportunity?

AVUV vs. VBR: Should You Make the Small-Cap Value Bet Active or Index?

Choose Advantage at 65, and One Health Change Can Lock You Out of Medigap for Good

Suze Orman Calls the 4% Rule 'Dangerous' — But the Data Tells a Different Story

Nvidia’s Biggest Threat Is This: Everyone Is Desperate to Stop Paying Nvidia Prices.

Does IREN Have the Inside Track on This $22 Billion Opportunity?

Pfizer : PFE

All Pfizer Articles

Pfizer Posts Positive Late-Stage Results in Colitis Trials

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Jefferies Top Drug Stocks for the Rest of 2016

The 4 Stocks That Dominated the Dow on Friday

Merrill Lynch Has 4 Outstanding Growth Stocks to Buy That Yield More Than 4%

Major Pharma Short Interest Takes a Small Step Back

The 5 Most Shorted NYSE Stocks: Chesapeake Energy Leads the Trend

Top Analyst Upgrades and Downgrades: AutoNation, Celldex, EP Energy, Shopify, Sony, Urban Outfitters, Valeant and More

Dogs of the Dow on Fire in 2016: 4 to Buy With Yields of 4% or More

The 4 Stocks That Sank the DJIA on Monday

Deutsche Bank Sees 4 Big Pharmaceutical Stocks as Cheap With Solid Dividends

The 4 Stocks That Weighed on the DJIA Friday

3 Highest Yielding Merrill Lynch US 1 Portfolio Stocks to Buy Now

Short Sellers Increase Bets in Major Pharma

Live Nasdaq Composite: Tech Propels Broader Markets Higher on Memory Stock Strength

Nvidia’s Biggest Threat Is This: Everyone Is Desperate to Stop Paying Nvidia Prices.

Does IREN Have the Inside Track on This $22 Billion Opportunity?

AVUV vs. VBR: Should You Make the Small-Cap Value Bet Active or Index?

Featured Reads

Choose Advantage at 65, and One Health Change Can Lock You Out of Medigap for Good

Suze Orman Calls the 4% Rule 'Dangerous' — But the Data Tells a Different Story